

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.22166043 |
| 2 | establishment of integrated proviral latency (GO:0075713) | 4.82193603 |
| 3 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.52541915 |
| 4 | cotranslational protein targeting to membrane (GO:0006613) | 4.50127310 |
| 5 | * COPI coating of Golgi vesicle (GO:0048205) | 4.48460041 |
| 6 | * Golgi transport vesicle coating (GO:0048200) | 4.48460041 |
| 7 | protein targeting to ER (GO:0045047) | 4.42041189 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 4.39582148 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.39582148 |
| 10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.32663803 |
| 11 | viral transcription (GO:0019083) | 4.30162293 |
| 12 | protein maturation by protein folding (GO:0022417) | 4.26503367 |
| 13 | protein localization to endoplasmic reticulum (GO:0070972) | 4.25435886 |
| 14 | establishment of viral latency (GO:0019043) | 4.17316442 |
| 15 | translational termination (GO:0006415) | 4.16364448 |
| 16 | nucleobase biosynthetic process (GO:0046112) | 4.15307399 |
| 17 | purine nucleobase biosynthetic process (GO:0009113) | 4.03238653 |
| 18 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.91161944 |
| 19 | ribosomal small subunit biogenesis (GO:0042274) | 3.88597721 |
| 20 | oxidative phosphorylation (GO:0006119) | 3.87867801 |
| 21 | formation of translation preinitiation complex (GO:0001731) | 3.81051981 |
| 22 | translational elongation (GO:0006414) | 3.78946426 |
| 23 | regulation of mitochondrial translation (GO:0070129) | 3.76844435 |
| 24 | ribosomal small subunit assembly (GO:0000028) | 3.75058282 |
| 25 | ribosomal large subunit biogenesis (GO:0042273) | 3.74580684 |
| 26 | viral life cycle (GO:0019058) | 3.68416251 |
| 27 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.66753246 |
| 28 | translational initiation (GO:0006413) | 3.64495553 |
| 29 | regulation of translational fidelity (GO:0006450) | 3.63898280 |
| 30 | respiratory electron transport chain (GO:0022904) | 3.61528294 |
| 31 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.59668764 |
| 32 | DNA strand elongation (GO:0022616) | 3.54692640 |
| 33 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.54678444 |
| 34 | translation (GO:0006412) | 3.52959548 |
| 35 | electron transport chain (GO:0022900) | 3.52891615 |
| 36 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.51028566 |
| 37 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.49762715 |
| 38 | signal peptide processing (GO:0006465) | 3.47748634 |
| 39 | tRNA aminoacylation for protein translation (GO:0006418) | 3.45137988 |
| 40 | tricarboxylic acid cycle (GO:0006099) | 3.41796067 |
| 41 | protein deneddylation (GO:0000338) | 3.40089559 |
| 42 | cellular protein complex disassembly (GO:0043624) | 3.37066758 |
| 43 | amino acid activation (GO:0043038) | 3.33181642 |
| 44 | tRNA aminoacylation (GO:0043039) | 3.33181642 |
| 45 | maturation of SSU-rRNA (GO:0030490) | 3.30179418 |
| 46 | cullin deneddylation (GO:0010388) | 3.28313828 |
| 47 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.24257832 |
| 48 | protein targeting to membrane (GO:0006612) | 3.19154046 |
| 49 | L-serine metabolic process (GO:0006563) | 3.19120111 |
| 50 | DNA deamination (GO:0045006) | 3.18664538 |
| 51 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.17473678 |
| 52 | protein targeting to mitochondrion (GO:0006626) | 3.16898512 |
| 53 | proteasome assembly (GO:0043248) | 3.16656423 |
| 54 | IMP biosynthetic process (GO:0006188) | 3.15948512 |
| 55 | protein complex disassembly (GO:0043241) | 3.09292957 |
| 56 | telomere maintenance via recombination (GO:0000722) | 3.08826138 |
| 57 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.08780640 |
| 58 | nuclear envelope reassembly (GO:0031468) | 3.07242683 |
| 59 | mitotic nuclear envelope reassembly (GO:0007084) | 3.07242683 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.06927146 |
| 61 | macromolecular complex disassembly (GO:0032984) | 3.06163920 |
| 62 | protein retention in ER lumen (GO:0006621) | 3.05490487 |
| 63 | tetrahydrofolate metabolic process (GO:0046653) | 3.02689595 |
| 64 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.02552039 |
| 65 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.02047539 |
| 66 | DNA replication checkpoint (GO:0000076) | 3.01577116 |
| 67 | protein localization to mitochondrion (GO:0070585) | 2.99022437 |
| 68 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.98381562 |
| 69 | establishment of protein localization to mitochondrion (GO:0072655) | 2.97892168 |
| 70 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.97703243 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.95654325 |
| 72 | chaperone-mediated protein transport (GO:0072321) | 2.94678233 |
| 73 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.94135692 |
| 74 | de novo protein folding (GO:0006458) | 2.91905498 |
| 75 | de novo posttranslational protein folding (GO:0051084) | 2.91782483 |
| 76 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.91307588 |
| 77 | DNA replication initiation (GO:0006270) | 2.90217085 |
| 78 | folic acid metabolic process (GO:0046655) | 2.89703830 |
| 79 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.89024367 |
| 80 | protein neddylation (GO:0045116) | 2.88853995 |
| 81 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.87737035 |
| 82 | mitochondrial fusion (GO:0008053) | 2.86543053 |
| 83 | aerobic respiration (GO:0009060) | 2.85844528 |
| 84 | * retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.84344231 |
| 85 | UMP metabolic process (GO:0046049) | 2.84233106 |
| 86 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.84233106 |
| 87 | UMP biosynthetic process (GO:0006222) | 2.84233106 |
| 88 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.84233106 |
| 89 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.82258017 |
| 90 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.81120832 |
| 91 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.80633283 |
| 92 | telomere maintenance via telomere lengthening (GO:0010833) | 2.79526111 |
| 93 | mitotic recombination (GO:0006312) | 2.77662478 |
| 94 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.77401398 |
| 95 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.76753665 |
| 96 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.76753665 |
| 97 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.76578780 |
| 98 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.76302118 |
| 99 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.76302118 |
| 100 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.76302118 |
| 101 | cellular component biogenesis (GO:0044085) | 2.76072252 |
| 102 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.72337550 |
| 103 | negative regulation of ligase activity (GO:0051352) | 2.72337550 |
| 104 | regulation of ligase activity (GO:0051340) | 2.70940397 |
| 105 | NADH metabolic process (GO:0006734) | 2.70381009 |
| 106 | protein localization to kinetochore (GO:0034501) | 2.70033526 |
| 107 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.68392853 |
| 108 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.67303923 |
| 109 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.67303923 |
| 110 | glycine metabolic process (GO:0006544) | 2.66830316 |
| 111 | protein complex biogenesis (GO:0070271) | 2.65855694 |
| 112 | folic acid-containing compound metabolic process (GO:0006760) | 2.65373942 |
| 113 | ribonucleoprotein complex disassembly (GO:0032988) | 2.65173539 |
| 114 | IMP metabolic process (GO:0046040) | 2.65015293 |
| 115 | proline biosynthetic process (GO:0006561) | 2.64819513 |
| 116 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.64674983 |
| 117 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.64423434 |
| 118 | pentose-phosphate shunt (GO:0006098) | 2.63417171 |
| 119 | serine family amino acid biosynthetic process (GO:0009070) | 2.63208026 |
| 120 | viral protein processing (GO:0019082) | 2.63122179 |
| 121 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.62885134 |
| 122 | ATP biosynthetic process (GO:0006754) | 2.62732849 |
| 123 | establishment of protein localization to membrane (GO:0090150) | 2.62436026 |
| 124 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.61703139 |
| 125 | GMP metabolic process (GO:0046037) | 2.61005490 |
| 126 | positive regulation of mitochondrial fission (GO:0090141) | 2.59578675 |
| 127 | mitochondrial transport (GO:0006839) | 2.59463177 |
| 128 | virion assembly (GO:0019068) | 2.58947942 |
| 129 | nucleoside salvage (GO:0043174) | 2.57940660 |
| 130 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.57696420 |
| 131 | amino acid salvage (GO:0043102) | 2.57339717 |
| 132 | L-methionine salvage (GO:0071267) | 2.57339717 |
| 133 | L-methionine biosynthetic process (GO:0071265) | 2.57339717 |
| 134 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.55755764 |
| 135 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.54638263 |
| 136 | pteridine-containing compound metabolic process (GO:0042558) | 2.54006154 |
| 137 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.53503773 |
| 138 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.53503773 |
| 139 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.52684636 |
| 140 | positive regulation of ligase activity (GO:0051351) | 2.52511021 |
| 141 | DNA unwinding involved in DNA replication (GO:0006268) | 2.51255183 |
| 142 | COPII vesicle coating (GO:0048208) | 2.50875348 |
| 143 | aldehyde catabolic process (GO:0046185) | 2.50568325 |
| 144 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.49911795 |
| 145 | sulfur amino acid biosynthetic process (GO:0000097) | 2.46265274 |
| 146 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.45262117 |
| 147 | cell cycle G1/S phase transition (GO:0044843) | 2.45262117 |
| 148 | mitotic nuclear envelope disassembly (GO:0007077) | 2.42427899 |
| 149 | one-carbon metabolic process (GO:0006730) | 2.41936380 |
| 150 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.40893171 |
| 151 | methionine biosynthetic process (GO:0009086) | 2.40363709 |
| 152 | ribosome biogenesis (GO:0042254) | 2.40095459 |
| 153 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.39816436 |
| 154 | L-phenylalanine metabolic process (GO:0006558) | 2.39816436 |
| 155 | purine-containing compound salvage (GO:0043101) | 2.39531123 |
| 156 | pseudouridine synthesis (GO:0001522) | 2.36505213 |
| 157 | purine nucleobase metabolic process (GO:0006144) | 2.34904197 |
| 158 | L-phenylalanine catabolic process (GO:0006559) | 2.34586419 |
| 159 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.34586419 |
| 160 | CENP-A containing nucleosome assembly (GO:0034080) | 2.33551150 |
| 161 | GDP-mannose metabolic process (GO:0019673) | 2.33089310 |
| 162 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.33082515 |
| 163 | mitotic metaphase plate congression (GO:0007080) | 2.31285747 |
| 164 | viral mRNA export from host cell nucleus (GO:0046784) | 2.31167272 |
| 165 | rRNA modification (GO:0000154) | 2.30841090 |
| 166 | peptide catabolic process (GO:0043171) | 2.30717473 |
| 167 | heme biosynthetic process (GO:0006783) | 2.29406092 |
| 168 | valine metabolic process (GO:0006573) | 2.28496811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.77508989 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.87847337 |
| 3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.39338158 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.30015433 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.21719380 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.02262615 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.97369184 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.95392373 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.77815872 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.60319714 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.57577767 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.55703912 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.53820707 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.30636910 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27614016 |
| 16 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.21213461 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.20545830 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.19478006 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.13169904 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09669186 |
| 21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.08340097 |
| 22 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.06934840 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.05981770 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.05803974 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.04525216 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99598156 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.97546326 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.96699927 |
| 29 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.94520803 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93711130 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.92257210 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87800340 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.87029508 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79793847 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.79591674 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77589066 |
| 37 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74140740 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.71900167 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71138191 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70823355 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.69107681 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67866210 |
| 43 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63459574 |
| 44 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62149389 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61869452 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.60998428 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.59869053 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56700275 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.54619696 |
| 50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.50162067 |
| 51 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.49576429 |
| 52 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.49118350 |
| 53 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.48238216 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48108504 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45301076 |
| 56 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.45099998 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44577011 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42854618 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41306124 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41284214 |
| 61 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.40767532 |
| 62 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.40395720 |
| 63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38168442 |
| 64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37755931 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33746458 |
| 66 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33715713 |
| 67 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31943194 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30424688 |
| 69 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.30233724 |
| 70 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.30058877 |
| 71 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.27252892 |
| 72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26860231 |
| 73 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.25614888 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.25456880 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23533347 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.23444574 |
| 77 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.21647857 |
| 78 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21049873 |
| 79 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20553493 |
| 80 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20469469 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20080938 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19091192 |
| 83 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.17937696 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17778288 |
| 85 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.17749077 |
| 86 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.15351502 |
| 87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12912903 |
| 88 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.11762154 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11515693 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11218179 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07620688 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07274049 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07029979 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06548407 |
| 95 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06055690 |
| 96 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05812437 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05004477 |
| 98 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.04340320 |
| 99 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03524250 |
| 100 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02723202 |
| 101 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01956288 |
| 102 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01202837 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00419346 |
| 104 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.99593405 |
| 105 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99280368 |
| 106 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98741858 |
| 107 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98653718 |
| 108 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98572911 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98560321 |
| 110 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.97043611 |
| 111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96620696 |
| 112 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96447760 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93678093 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92800168 |
| 115 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90960884 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90815818 |
| 117 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89507414 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89445141 |
| 119 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89214886 |
| 120 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87496602 |
| 121 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.84592405 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84477103 |
| 123 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.84038334 |
| 124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84031245 |
| 125 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.83309452 |
| 126 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.82860746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.64855921 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.58115505 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.41754316 |
| 4 | MP0005360_urolithiasis | 2.99261749 |
| 5 | MP0005365_abnormal_bile_salt | 2.92087320 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.59854459 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.57481706 |
| 8 | MP0010030_abnormal_orbit_morphology | 2.56335853 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.53815349 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.42399287 |
| 11 | MP0003186_abnormal_redox_activity | 2.40858811 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.40697911 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.29774746 |
| 14 | MP0003077_abnormal_cell_cycle | 2.26926198 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.20174350 |
| 16 | MP0006054_spinal_hemorrhage | 2.10519767 |
| 17 | MP0001529_abnormal_vocalization | 2.09704038 |
| 18 | MP0008058_abnormal_DNA_repair | 2.08077479 |
| 19 | MP0008007_abnormal_cellular_replicative | 1.92712450 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.86607333 |
| 21 | MP0005248_abnormal_Harderian_gland | 1.86361882 |
| 22 | MP0009840_abnormal_foam_cell | 1.82059000 |
| 23 | MP0006035_abnormal_mitochondrial_morpho | 1.79646274 |
| 24 | MP0008057_abnormal_DNA_replication | 1.79110729 |
| 25 | MP0001764_abnormal_homeostasis | 1.78870479 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76539037 |
| 27 | MP0002938_white_spotting | 1.75291740 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.71021092 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.67885654 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.66892199 |
| 31 | MP0005083_abnormal_biliary_tract | 1.64129245 |
| 32 | MP0001727_abnormal_embryo_implantation | 1.62966867 |
| 33 | MP0009697_abnormal_copulation | 1.61463874 |
| 34 | MP0003123_paternal_imprinting | 1.60949560 |
| 35 | MP0000490_abnormal_crypts_of | 1.60459394 |
| 36 | MP0008789_abnormal_olfactory_epithelium | 1.59901223 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.58026219 |
| 38 | MP0001346_abnormal_lacrimal_gland | 1.48528780 |
| 39 | MP0003436_decreased_susceptibility_to | 1.46728249 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 1.45600338 |
| 41 | MP0003195_calcinosis | 1.43828487 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.41541785 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.39469521 |
| 44 | MP0009785_altered_susceptibility_to | 1.38157721 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.33899134 |
| 46 | MP0004147_increased_porphyrin_level | 1.33379097 |
| 47 | MP0002132_abnormal_respiratory_system | 1.32788015 |
| 48 | MP0002163_abnormal_gland_morphology | 1.32745243 |
| 49 | MP0008932_abnormal_embryonic_tissue | 1.32710362 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.31918954 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.31918954 |
| 52 | MP0005332_abnormal_amino_acid | 1.31554829 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 1.31081729 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.30407224 |
| 55 | MP0005501_abnormal_skin_physiology | 1.29142414 |
| 56 | MP0000462_abnormal_digestive_system | 1.27009312 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.26118365 |
| 58 | MP0005408_hypopigmentation | 1.25879006 |
| 59 | MP0006072_abnormal_retinal_apoptosis | 1.25873560 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.25258692 |
| 61 | MP0004272_abnormal_basement_membrane | 1.22878358 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.22490629 |
| 63 | MP0003315_abnormal_perineum_morphology | 1.22159758 |
| 64 | MP0005499_abnormal_olfactory_system | 1.20397212 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.20397212 |
| 66 | MP0000609_abnormal_liver_physiology | 1.19920201 |
| 67 | MP0004233_abnormal_muscle_weight | 1.18981282 |
| 68 | MP0000598_abnormal_liver_morphology | 1.18239620 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.17169048 |
| 70 | MP0001697_abnormal_embryo_size | 1.16506621 |
| 71 | MP0009643_abnormal_urine_homeostasis | 1.15334392 |
| 72 | MP0002653_abnormal_ependyma_morphology | 1.15086857 |
| 73 | MP0002697_abnormal_eye_size | 1.13824289 |
| 74 | MP0002019_abnormal_tumor_incidence | 1.12938208 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 1.12664168 |
| 76 | MP0001853_heart_inflammation | 1.10945807 |
| 77 | MP0000566_synostosis | 1.10358689 |
| 78 | MP0005025_abnormal_response_to | 1.09434574 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 1.09361660 |
| 80 | MP0003566_abnormal_cell_adhesion | 1.08804844 |
| 81 | MP0001730_embryonic_growth_arrest | 1.08802065 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 1.08730149 |
| 83 | MP0003763_abnormal_thymus_physiology | 1.08562368 |
| 84 | MP0005671_abnormal_response_to | 1.07952103 |
| 85 | MP0003011_delayed_dark_adaptation | 1.07656108 |
| 86 | MP0001661_extended_life_span | 1.07171802 |
| 87 | MP0003252_abnormal_bile_duct | 1.06542855 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 1.06497728 |
| 89 | MP0002084_abnormal_developmental_patter | 1.06392414 |
| 90 | MP0001672_abnormal_embryogenesis/_devel | 1.06277673 |
| 91 | MP0005380_embryogenesis_phenotype | 1.06277673 |
| 92 | MP0000537_abnormal_urethra_morphology | 1.06136852 |
| 93 | MP0002085_abnormal_embryonic_tissue | 1.06073662 |
| 94 | MP0002419_abnormal_innate_immunity | 1.05306980 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 1.05227576 |
| 96 | MP0008469_abnormal_protein_level | 1.04652040 |
| 97 | MP0002398_abnormal_bone_marrow | 1.04028601 |
| 98 | MP0000858_altered_metastatic_potential | 1.03813008 |
| 99 | MP0003942_abnormal_urinary_system | 1.03176524 |
| 100 | MP0008995_early_reproductive_senescence | 1.02250754 |
| 101 | MP0000689_abnormal_spleen_morphology | 1.01784503 |
| 102 | MP0000678_abnormal_parathyroid_gland | 1.01519007 |
| 103 | MP0004019_abnormal_vitamin_homeostasis | 1.01490626 |
| 104 | MP0000350_abnormal_cell_proliferation | 1.00878258 |
| 105 | MP0005636_abnormal_mineral_homeostasis | 1.00619020 |
| 106 | MP0002837_dystrophic_cardiac_calcinosis | 1.00058770 |
| 107 | MP0000685_abnormal_immune_system | 0.99340707 |
| 108 | MP0003984_embryonic_growth_retardation | 0.99083680 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.99068022 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.98515427 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.97898204 |
| 112 | MP0002429_abnormal_blood_cell | 0.97670595 |
| 113 | MP0002722_abnormal_immune_system | 0.94377307 |
| 114 | MP0001293_anophthalmia | 0.93563350 |
| 115 | MP0001881_abnormal_mammary_gland | 0.93428522 |
| 116 | MP0003724_increased_susceptibility_to | 0.93116230 |
| 117 | MP0008260_abnormal_autophagy | 0.92473584 |
| 118 | MP0002088_abnormal_embryonic_growth/wei | 0.92279672 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.91969454 |
| 120 | MP0003718_maternal_effect | 0.91054443 |
| 121 | MP0002090_abnormal_vision | 0.90345513 |
| 122 | MP0000313_abnormal_cell_death | 0.89954915 |
| 123 | MP0001905_abnormal_dopamine_level | 0.89789804 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.89516921 |
| 125 | MP0003385_abnormal_body_wall | 0.89318558 |
| 126 | MP0000013_abnormal_adipose_tissue | 0.88704817 |
| 127 | MP0003786_premature_aging | 0.88474974 |
| 128 | MP0002233_abnormal_nose_morphology | 0.88355148 |
| 129 | MP0003122_maternal_imprinting | 0.87631275 |
| 130 | MP0002452_abnormal_antigen_presenting | 0.87248950 |
| 131 | MP0004808_abnormal_hematopoietic_stem | 0.86602982 |
| 132 | MP0000358_abnormal_cell_content/ | 0.84716797 |
| 133 | MP0000716_abnormal_immune_system | 0.84548026 |
| 134 | MP0002405_respiratory_system_inflammati | 0.84461132 |
| 135 | MP0001756_abnormal_urination | 0.84328471 |
| 136 | MP0000681_abnormal_thyroid_gland | 0.84170984 |
| 137 | MP0001944_abnormal_pancreas_morphology | 0.83794369 |
| 138 | MP0001819_abnormal_immune_cell | 0.83702603 |
| 139 | MP0002420_abnormal_adaptive_immunity | 0.83357909 |
| 140 | MP0005000_abnormal_immune_tolerance | 0.83310181 |
| 141 | MP0001800_abnormal_humoral_immune | 0.82770126 |
| 142 | MP0005075_abnormal_melanosome_morpholog | 0.81515474 |
| 143 | MP0000377_abnormal_hair_follicle | 0.81495667 |
| 144 | MP0005084_abnormal_gallbladder_morpholo | 0.81103078 |
| 145 | MP0003943_abnormal_hepatobiliary_system | 0.80886720 |
| 146 | MP0002693_abnormal_pancreas_physiology | 0.79540057 |
| 147 | MP0002080_prenatal_lethality | 0.79341507 |
| 148 | MP0010307_abnormal_tumor_latency | 0.78831860 |
| 149 | MP0002723_abnormal_immune_serum | 0.77958834 |
| 150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77212734 |
| 151 | MP0009763_increased_sensitivity_to | 0.77102699 |
| 152 | MP0002098_abnormal_vibrissa_morphology | 0.77068210 |
| 153 | MP0009764_decreased_sensitivity_to | 0.76724019 |
| 154 | MP0002282_abnormal_trachea_morphology | 0.76573412 |
| 155 | MP0000372_irregular_coat_pigmentation | 0.76256912 |
| 156 | MP0005645_abnormal_hypothalamus_physiol | 0.76077221 |
| 157 | MP0000750_abnormal_muscle_regeneration | 0.74903807 |
| 158 | MP0002111_abnormal_tail_morphology | 0.74822633 |
| 159 | MP0001286_abnormal_eye_development | 0.74215400 |
| 160 | MP0001243_abnormal_dermal_layer | 0.74139323 |
| 161 | MP0002234_abnormal_pharynx_morphology | 0.72056771 |
| 162 | MP0001533_abnormal_skeleton_physiology | 0.71962953 |
| 163 | MP0003937_abnormal_limbs/digits/tail_de | 0.71401670 |
| 164 | MP0003755_abnormal_palate_morphology | 0.70015619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.29869508 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.27525729 |
| 3 | Acute encephalopathy (HP:0006846) | 4.04951678 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.82296684 |
| 5 | Increased hepatocellular lipid droplets (HP:0006565) | 3.80936200 |
| 6 | Microvesicular hepatic steatosis (HP:0001414) | 3.73226003 |
| 7 | Cholecystitis (HP:0001082) | 3.52084164 |
| 8 | Abnormal gallbladder physiology (HP:0012438) | 3.52084164 |
| 9 | Aplastic anemia (HP:0001915) | 3.51511931 |
| 10 | Lipid accumulation in hepatocytes (HP:0006561) | 3.48337286 |
| 11 | Increased CSF lactate (HP:0002490) | 3.47355022 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.41681920 |
| 13 | Cerebral edema (HP:0002181) | 3.41376252 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.38722550 |
| 15 | Progressive macrocephaly (HP:0004481) | 3.37006009 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 3.21816499 |
| 17 | Generalized aminoaciduria (HP:0002909) | 3.16246254 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.14373698 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.06475409 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 3.03048971 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.02101748 |
| 22 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.00470223 |
| 23 | Macrocytic anemia (HP:0001972) | 2.98006812 |
| 24 | Thrombocytosis (HP:0001894) | 2.93758835 |
| 25 | Degeneration of anterior horn cells (HP:0002398) | 2.93540689 |
| 26 | Abnormality of the anterior horn cell (HP:0006802) | 2.93540689 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 2.92882193 |
| 28 | Reduced antithrombin III activity (HP:0001976) | 2.89132267 |
| 29 | Lactic acidosis (HP:0003128) | 2.79866821 |
| 30 | Oral leukoplakia (HP:0002745) | 2.76586690 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 2.70658901 |
| 32 | Nonimmune hydrops fetalis (HP:0001790) | 2.66466657 |
| 33 | Exercise intolerance (HP:0003546) | 2.64908859 |
| 34 | Petechiae (HP:0000967) | 2.64507127 |
| 35 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.62503063 |
| 36 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.62503063 |
| 37 | Abnormal protein glycosylation (HP:0012346) | 2.62503063 |
| 38 | Abnormal glycosylation (HP:0012345) | 2.62503063 |
| 39 | Respiratory failure (HP:0002878) | 2.62375690 |
| 40 | Hyperbilirubinemia (HP:0002904) | 2.62323637 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.60415831 |
| 42 | Birth length less than 3rd percentile (HP:0003561) | 2.57654321 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.49541986 |
| 44 | Hepatic necrosis (HP:0002605) | 2.47704058 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.44642491 |
| 46 | Poor head control (HP:0002421) | 2.44576801 |
| 47 | Increased muscle lipid content (HP:0009058) | 2.42023509 |
| 48 | Intrahepatic cholestasis (HP:0001406) | 2.41392460 |
| 49 | Multiple enchondromatosis (HP:0005701) | 2.41045548 |
| 50 | Overlapping toe (HP:0001845) | 2.39938655 |
| 51 | Abnormality of reticulocytes (HP:0004312) | 2.35178342 |
| 52 | Hyperammonemia (HP:0001987) | 2.31984823 |
| 53 | Abnormality of the common coagulation pathway (HP:0010990) | 2.28438453 |
| 54 | Nausea (HP:0002018) | 2.27789521 |
| 55 | Cortical dysplasia (HP:0002539) | 2.26488264 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.21327384 |
| 57 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.17270630 |
| 58 | Hypokinesia (HP:0002375) | 2.15963893 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.14599541 |
| 60 | Upper limb muscle weakness (HP:0003484) | 2.14463131 |
| 61 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.13809792 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.13422320 |
| 63 | Neuroendocrine neoplasm (HP:0100634) | 2.12825179 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.11466592 |
| 65 | Cholelithiasis (HP:0001081) | 2.09139878 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08926839 |
| 67 | Opisthotonus (HP:0002179) | 2.07909376 |
| 68 | Orthostatic hypotension (HP:0001278) | 2.06735095 |
| 69 | Microretrognathia (HP:0000308) | 2.04303012 |
| 70 | Myoglobinuria (HP:0002913) | 2.02603333 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.01408095 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01408095 |
| 73 | Fat malabsorption (HP:0002630) | 2.01339978 |
| 74 | Respiratory difficulties (HP:0002880) | 2.01006266 |
| 75 | Megaloblastic anemia (HP:0001889) | 2.00529228 |
| 76 | 11 pairs of ribs (HP:0000878) | 1.99734542 |
| 77 | Abnormality of methionine metabolism (HP:0010901) | 1.98468508 |
| 78 | Rough bone trabeculation (HP:0100670) | 1.96774149 |
| 79 | Increased serum lactate (HP:0002151) | 1.96046778 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 1.95325694 |
| 81 | Leukodystrophy (HP:0002415) | 1.95201168 |
| 82 | Testicular atrophy (HP:0000029) | 1.94156161 |
| 83 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.93997477 |
| 84 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.93997477 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 1.93710847 |
| 86 | Postnatal microcephaly (HP:0005484) | 1.93612475 |
| 87 | Abnormal number of erythroid precursors (HP:0012131) | 1.93238777 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 1.90862666 |
| 89 | Emotional lability (HP:0000712) | 1.90768911 |
| 90 | IgM deficiency (HP:0002850) | 1.89675388 |
| 91 | Hyperphosphaturia (HP:0003109) | 1.89376620 |
| 92 | Hypolipoproteinemia (HP:0010981) | 1.88822874 |
| 93 | Hepatocellular necrosis (HP:0001404) | 1.88699566 |
| 94 | Reticulocytosis (HP:0001923) | 1.88233019 |
| 95 | Gout (HP:0001997) | 1.87860805 |
| 96 | Beaking of vertebral bodies (HP:0004568) | 1.87590952 |
| 97 | Abnormality of glycolysis (HP:0004366) | 1.86660271 |
| 98 | Increased serum pyruvate (HP:0003542) | 1.86660271 |
| 99 | Hyperthyroidism (HP:0000836) | 1.85737542 |
| 100 | Steatorrhea (HP:0002570) | 1.85534805 |
| 101 | Neoplasm of the adrenal gland (HP:0100631) | 1.85129236 |
| 102 | Deep venous thrombosis (HP:0002625) | 1.84841294 |
| 103 | Hyperglycinuria (HP:0003108) | 1.84650289 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 1.84392729 |
| 105 | Trismus (HP:0000211) | 1.83133352 |
| 106 | Cerebral palsy (HP:0100021) | 1.81675787 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 1.81608078 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.80992571 |
| 109 | Irregular epiphyses (HP:0010582) | 1.80632298 |
| 110 | Poikilocytosis (HP:0004447) | 1.80531303 |
| 111 | Xanthomatosis (HP:0000991) | 1.79899378 |
| 112 | Unilateral renal agenesis (HP:0000122) | 1.78404951 |
| 113 | Pancytopenia (HP:0001876) | 1.78238258 |
| 114 | Abnormality of serum amino acid levels (HP:0003112) | 1.77705104 |
| 115 | Reticulocytopenia (HP:0001896) | 1.77150285 |
| 116 | Abnormality of renal resorption (HP:0011038) | 1.77040643 |
| 117 | Lethargy (HP:0001254) | 1.76626225 |
| 118 | Vertebral compression fractures (HP:0002953) | 1.76062658 |
| 119 | Carpal bone hypoplasia (HP:0001498) | 1.75799021 |
| 120 | Joint hemorrhage (HP:0005261) | 1.75585060 |
| 121 | Conjugated hyperbilirubinemia (HP:0002908) | 1.74670535 |
| 122 | Hyperglycinemia (HP:0002154) | 1.74549900 |
| 123 | Secondary amenorrhea (HP:0000869) | 1.74045045 |
| 124 | Neutropenia (HP:0001875) | 1.73682799 |
| 125 | Abnormality of urine glucose concentration (HP:0011016) | 1.72805310 |
| 126 | Glycosuria (HP:0003076) | 1.72805310 |
| 127 | Proximal tubulopathy (HP:0000114) | 1.72725388 |
| 128 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.72361193 |
| 129 | Prominent metopic ridge (HP:0005487) | 1.72044510 |
| 130 | Abnormality of purine metabolism (HP:0004352) | 1.71664201 |
| 131 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71561087 |
| 132 | Breast hypoplasia (HP:0003187) | 1.71126511 |
| 133 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.70529956 |
| 134 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.70376980 |
| 135 | Metabolic acidosis (HP:0001942) | 1.69561528 |
| 136 | Rhabdomyolysis (HP:0003201) | 1.68894109 |
| 137 | Hand muscle atrophy (HP:0009130) | 1.68591261 |
| 138 | Poor suck (HP:0002033) | 1.68529845 |
| 139 | Premature rupture of membranes (HP:0001788) | 1.68186341 |
| 140 | Bone marrow hypocellularity (HP:0005528) | 1.67813895 |
| 141 | Hypoplastic pelvis (HP:0008839) | 1.67596379 |
| 142 | Ketosis (HP:0001946) | 1.67585338 |
| 143 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.66731941 |
| 144 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.65718300 |
| 145 | Abnormality of the gallbladder (HP:0005264) | 1.65397051 |
| 146 | Complement deficiency (HP:0004431) | 1.65287651 |
| 147 | Insidious onset (HP:0003587) | 1.64601605 |
| 148 | Termporal pattern (HP:0011008) | 1.64601605 |
| 149 | Late onset (HP:0003584) | 1.64580554 |
| 150 | Recurrent abscess formation (HP:0002722) | 1.64439919 |
| 151 | CNS demyelination (HP:0007305) | 1.64343674 |
| 152 | Villous atrophy (HP:0011473) | 1.63443607 |
| 153 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.63443607 |
| 154 | Truncus arteriosus (HP:0001660) | 1.63365370 |
| 155 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.63159736 |
| 156 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.63159736 |
| 157 | Ragged-red muscle fibers (HP:0003200) | 1.62652669 |
| 158 | Exertional dyspnea (HP:0002875) | 1.62534409 |
| 159 | Symptomatic seizures (HP:0011145) | 1.62293373 |
| 160 | Anorexia (HP:0002039) | 1.61621052 |
| 161 | Congenital primary aphakia (HP:0007707) | 1.61567142 |
| 162 | Pallor (HP:0000980) | 1.61276653 |
| 163 | Abnormality of dentin (HP:0010299) | 1.58197836 |
| 164 | Adrenal hypoplasia (HP:0000835) | 1.57944376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.05642941 |
| 2 | EIF2AK1 | 3.53087308 |
| 3 | BUB1 | 3.17500568 |
| 4 | STK16 | 2.89205950 |
| 5 | BCKDK | 2.80540842 |
| 6 | PASK | 2.60752453 |
| 7 | EIF2AK3 | 2.52554962 |
| 8 | WEE1 | 2.38190197 |
| 9 | TSSK6 | 2.24803604 |
| 10 | NME1 | 2.23868178 |
| 11 | ERN1 | 2.11029410 |
| 12 | CDC7 | 1.95523313 |
| 13 | NME2 | 1.88685255 |
| 14 | TESK1 | 1.88317816 |
| 15 | MST1R | 1.83654029 |
| 16 | ACVR1B | 1.80512244 |
| 17 | IRAK3 | 1.76125717 |
| 18 | NEK1 | 1.75611480 |
| 19 | BRSK2 | 1.74051770 |
| 20 | PIM2 | 1.73112614 |
| 21 | PLK4 | 1.72312221 |
| 22 | TGFBR1 | 1.64516901 |
| 23 | TESK2 | 1.53965669 |
| 24 | ZAP70 | 1.49832294 |
| 25 | MAP4K1 | 1.46866156 |
| 26 | VRK1 | 1.45731256 |
| 27 | EPHA3 | 1.45317140 |
| 28 | PDK2 | 1.44444048 |
| 29 | SCYL2 | 1.43974713 |
| 30 | ILK | 1.43428202 |
| 31 | FLT3 | 1.43305113 |
| 32 | SRPK1 | 1.39545469 |
| 33 | IRAK4 | 1.38985914 |
| 34 | MAP2K7 | 1.38745237 |
| 35 | RPS6KA4 | 1.37696020 |
| 36 | CSNK1G3 | 1.35419814 |
| 37 | BRSK1 | 1.33733409 |
| 38 | BCR | 1.31535214 |
| 39 | EPHB2 | 1.19552457 |
| 40 | MAP3K11 | 1.18595166 |
| 41 | STK10 | 1.16908717 |
| 42 | KDR | 1.16619348 |
| 43 | NEK9 | 1.15017453 |
| 44 | PLK1 | 1.12640250 |
| 45 | PLK3 | 1.12581801 |
| 46 | RPS6KB2 | 1.12409405 |
| 47 | ATR | 1.11416409 |
| 48 | NEK2 | 1.10273505 |
| 49 | LMTK2 | 1.09731202 |
| 50 | TYK2 | 1.05424259 |
| 51 | ERBB3 | 1.04221000 |
| 52 | CDK7 | 1.02794275 |
| 53 | MAP3K12 | 1.00887234 |
| 54 | CDK8 | 0.99363598 |
| 55 | BTK | 0.99192082 |
| 56 | AURKB | 0.98857409 |
| 57 | TRIM28 | 0.98676065 |
| 58 | CCNB1 | 0.98626703 |
| 59 | AKT3 | 0.98228004 |
| 60 | TTK | 0.97811869 |
| 61 | MAPKAPK3 | 0.96911926 |
| 62 | PAK4 | 0.96710541 |
| 63 | EPHB1 | 0.96601254 |
| 64 | CSNK1A1L | 0.95891355 |
| 65 | KIT | 0.94537774 |
| 66 | TAOK3 | 0.93794695 |
| 67 | PIM1 | 0.93538807 |
| 68 | CDK19 | 0.93201781 |
| 69 | MAP2K3 | 0.92622038 |
| 70 | MET | 0.92140023 |
| 71 | TBK1 | 0.92050340 |
| 72 | JAK3 | 0.90513154 |
| 73 | AURKA | 0.89183083 |
| 74 | CSNK1G1 | 0.89151703 |
| 75 | TEC | 0.88745084 |
| 76 | BRAF | 0.87821765 |
| 77 | ZAK | 0.87632124 |
| 78 | ARAF | 0.85790262 |
| 79 | TXK | 0.84860839 |
| 80 | BLK | 0.84588190 |
| 81 | CSNK1G2 | 0.84558368 |
| 82 | DYRK3 | 0.83867114 |
| 83 | SIK3 | 0.82746983 |
| 84 | DYRK2 | 0.80561851 |
| 85 | TAOK2 | 0.80001773 |
| 86 | LIMK1 | 0.79916904 |
| 87 | MAP3K8 | 0.78512224 |
| 88 | EIF2AK2 | 0.77383415 |
| 89 | PBK | 0.77265426 |
| 90 | DAPK1 | 0.77149761 |
| 91 | FER | 0.73640992 |
| 92 | ERBB4 | 0.71963688 |
| 93 | FGFR4 | 0.71523297 |
| 94 | CDK14 | 0.69611594 |
| 95 | MAPKAPK5 | 0.68505267 |
| 96 | PKN2 | 0.67118911 |
| 97 | MYLK | 0.66765928 |
| 98 | IKBKE | 0.66758293 |
| 99 | EPHA2 | 0.66048110 |
| 100 | AKT2 | 0.65866063 |
| 101 | LRRK2 | 0.64697835 |
| 102 | MAP3K3 | 0.64674941 |
| 103 | MKNK1 | 0.63971261 |
| 104 | EEF2K | 0.63139522 |
| 105 | PTK2 | 0.63052968 |
| 106 | CDK4 | 0.62899406 |
| 107 | ABL2 | 0.62882683 |
| 108 | MAP3K14 | 0.62307646 |
| 109 | MAP4K2 | 0.62101562 |
| 110 | CSNK2A1 | 0.62092993 |
| 111 | MAP3K4 | 0.61978639 |
| 112 | DAPK3 | 0.61368103 |
| 113 | PAK1 | 0.60794445 |
| 114 | MAPK11 | 0.60689954 |
| 115 | RAF1 | 0.60448397 |
| 116 | STK4 | 0.59929385 |
| 117 | TRIB3 | 0.59847252 |
| 118 | TGFBR2 | 0.58764625 |
| 119 | CDK11A | 0.58672122 |
| 120 | KSR1 | 0.57846799 |
| 121 | LYN | 0.56246824 |
| 122 | IKBKB | 0.56136937 |
| 123 | CHUK | 0.56125826 |
| 124 | SYK | 0.54919365 |
| 125 | PIK3CG | 0.54432183 |
| 126 | CDK18 | 0.54349723 |
| 127 | CSF1R | 0.53439631 |
| 128 | BMPR1B | 0.52062599 |
| 129 | CDK15 | 0.51322940 |
| 130 | CHEK2 | 0.50545295 |
| 131 | CLK1 | 0.50264409 |
| 132 | KSR2 | 0.50063401 |
| 133 | PHKG2 | 0.49908649 |
| 134 | PHKG1 | 0.49908649 |
| 135 | MAP3K5 | 0.49892027 |
| 136 | PRKCI | 0.49825346 |
| 137 | MST4 | 0.49461334 |
| 138 | PRKG2 | 0.48682647 |
| 139 | BMX | 0.48351488 |
| 140 | ICK | 0.47008628 |
| 141 | STK38L | 0.45907846 |
| 142 | RPS6KB1 | 0.45068656 |
| 143 | CSNK2A2 | 0.44067090 |
| 144 | STK24 | 0.43065599 |
| 145 | MAP2K6 | 0.42899516 |
| 146 | SMG1 | 0.42358838 |
| 147 | CAMK2G | 0.34986740 |
| 148 | CHEK1 | 0.33961324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.39397724 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.20491617 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.15471914 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.78044856 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.77341367 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.69594590 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.54034389 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.27758246 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.23122911 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.01322655 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.98669806 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 1.96485475 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.92707517 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.86710562 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.84993485 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.83015343 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.77936629 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.76031833 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.71848032 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.70729920 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70060896 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.65720325 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.65139675 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.62447239 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.61976811 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.58238422 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.56527482 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.55785698 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.54398766 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.51537912 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.49384907 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.47783456 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.47526911 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.47109588 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45551945 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44110033 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42098867 |
| 38 | Cell cycle_Homo sapiens_hsa04110 | 1.40742130 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36426276 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35347502 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33346615 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32205735 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.27064756 |
| 44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26292449 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23114688 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.22170297 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.21566071 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.20247862 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.20004367 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18680552 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18435676 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17015763 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 1.16815643 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.13374370 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12962480 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11594992 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.10039712 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04375108 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 1.01650537 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01236304 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97813601 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97144919 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94964737 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94303479 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92838524 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90171073 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88068494 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87931262 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.87402973 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86084027 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85623349 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82694131 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82436013 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82382864 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80785883 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79691974 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79280903 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74700037 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73792518 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73299971 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72825080 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71357755 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71318532 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69023168 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68514622 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68479199 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67132303 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66210283 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66048120 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64821044 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64651489 |
| 92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63373737 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62854452 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58796575 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55913778 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54163307 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53245014 |
| 98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.52709860 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52452257 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51454280 |
| 101 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51016378 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47064037 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.46318028 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44870336 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44505774 |
| 106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44337630 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43342604 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41182950 |
| 109 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40664835 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39438439 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38702678 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.37815643 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35535419 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35358592 |
| 115 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33886952 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33722064 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33192423 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30902852 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.30091255 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27667716 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.25232046 |
| 122 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.12458314 |
| 123 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.10328152 |

